Single-Cell Multi-Omics for Solid Tumor and Hematologic Malignancies Research

Join Mission Bio for an interactive virtual seminar highlighting the key advantages of single-cell technology that simultaneously measures single-nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.

We are happy to welcome Dr. Sandra Misale, Memorial Sloan Kettering Cancer Center. She will present data from her latest publication “Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers.” (2022).

In addition, Simone Formisano will give an introduction to Mission Bio’s Tapestri capabilities on SNV, CNV, and protein sequencing at scale, the workflow and its applications in oncology and cell and gene therapy.